FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16054711000001104: Hydroxychloroquine 200mg tablets (Bristol Laboratories Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Nov 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
56625801000001114 Hydroxychloroquine 200mg tablets (Bristol Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
56625901000001115 Hydroxychloroquine 200mg tablets (Bristol Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Hydroxychloroquine 200mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Bristol Laboratories Ltd) Is a Product containing precisely hydroxychloroquine sulfate 200 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Bristol Laboratories Ltd) Has active ingredient Hydroxychloroquine sulfate false Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Bristol Laboratories Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Bristol Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Bristol Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Bristol Laboratories Ltd) Has specific active ingredient Hydroxychloroquine sulfate true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Bristol Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Bristol Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Hydroxychloroquine 200mg tablets (Bristol Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Hydroxychloroquine 200mg tablets (Bristol Laboratories Ltd) 60 tablet 6 x 10 tablets Has AMP True Hydroxychloroquine 200mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start